Vaccines have saved millions of lives, but nobody likes getting a shot. That’s why scientists are trying to develop oral vaccines for infectious diseases.
But to be effective, the vaccine must survive digestion and reach immune cells within the intestinal wall. Now, researchers reporting in the ACS journal Nano Letters have developed oral vaccines powered by micromotors that target the mucus layer of the intestine.
In addition to avoiding needles, oral vaccines can generate a broader immune response by stimulating immune cells within the mucus layer of the intestine to produce a special class of antibody called immunoglobulin A (IgA). Joseph Wang, Liangfang Zhang and colleagues wondered if they could use magnesium particles as tiny motors to deliver an oral vaccine against the bacterial pathogen Staphylococcus aureus. When coated over most of their surfaces with titanium dioxide, magnesium microparticles use water as fuel to generate hydrogen bubbles that power their propulsion.
To develop the oral vaccine, the researchers coated magnesium micromotors with red blood cell membranes that displayed the Staphylococcal ?-toxin, along with a layer of chitosan to help them stick to the intestinal mucus. Then, they added an enteric coating that protects drugs from the acidic conditions of the stomach. When given orally to mice, the micromotors safely passed through the stomach, and then the enteric coating dissolved, activating the motors. Imaging of mice that had been given the vaccine showed that the micromotors accumulated in the intestinal wall much better than non-motorized particles. The micromotors also stimulated the production of about ten times more IgA antibodies against the Staphylococcal ?-toxin than the static particles.
Learn more: Micromotors deliver oral vaccines
The Latest on: Oral vaccines
via Google News
The Latest on: Oral vaccines
- 4 Biotechs Likely to Gain on Coronavirus Vaccine Effortson November 27, 2020 at 6:11 am
The much-awaited coronavirus vaccine is likely to be available for emergency use by mid-December. Several pharma bigwigs as well as biotech companies have been working relentlessly to bring a vaccine ...
- Global Veterinary Vaccine Adjuvants Market Analysis by Size, Segment and Evolution Rate by Type and Application Forecast by 2025on November 26, 2020 at 1:32 pm
Selbyville, Delaware, Global Veterinary Vaccine Adjuvants Market report added by Market Study Report that gives meticulous investigation of current scenario of the market size, share, demand, growth, ...
- Global Oral Vaccines Market 2020 Segmentation, Future Business Strategy, Manufacturers Analysis and Forecast by 2025on November 26, 2020 at 12:57 am
The latest extensive, professional market study titled Global Oral Vaccines Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 firstly enfolds a comprehensive analysis and ...
- The Covid-19 Vaccine: When Will It Be Available for You?on November 25, 2020 at 6:22 pm
This is what we know and don’t know about how, and when, the coronavirus vaccine is likely to reach Americans, from high-risk people and essential workers to those in the general population.
- Slaoui Sees More Work Ahead as Vaccines Near Finish Lineon November 24, 2020 at 1:26 pm
As Slaoui nears the milestone he set out to achieve, Operation Warp Speed’s chief scientific adviser says there's still more to accomplish. U.S. health officials must carry out a complex mass ...
- Key Capital Licenses Immunitor Oral Pill Immunotherapeutic Vaccineson November 24, 2020 at 9:46 am
Key Capital to advance development of breakthrough patented oral pill immunotherapeutics. NEW YORK, NY / ACCESSWIRE / November 24, 2020 / KEY CAPITAL CORPORATION (OTC PINK:KCPC) a ...
- Global Typhoid Fever Vaccines Markets to 2027: Development of Innovative and Potent Vaccine Candidates Gaining Momentumon November 24, 2020 at 12:50 am
The "Typhoid Fever Vaccines Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Vaccine Type; Route of administration, and Geography." report has been added to ResearchAndMarkets.com's ...
- Whistleblower Cases Are A Warning To Covid-19 Vaccine Makerson November 20, 2020 at 2:15 pm
As pharma companies race to develop and manufacture Covid-19 vaccines, they should take heed of two important whistleblower cases.
- Scientists race to find 'warm' Covid vaccine to solve issue of cold storageon November 20, 2020 at 12:25 am
News that one of the potential coronavirus vaccines had at least a 90% efficacy rate was a “victory for science”, said K Srinath Reddy, a cardiologist and president of the Public Health Foundation of ...
- Covid vaccine hopeful subleases space on Peninsulaon November 19, 2020 at 3:02 pm
Vaxart Inc. will sublease 24,606 square feet in South San Francisco as it pursues an oral vaccine against Covid-19, the flu and more. The company said in a Securities and Exchange Commission filing ...
via Bing News